Biolytx Pharmaceuticals
Biolytx Pharmaceuticals developing a drug focused on promoting wound healing and killing antibiotic resistant bacteria. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€4—6m (Dealroom.co estimates Nov 2015.)
Oklahoma City Oklahoma (HQ)
Authorizing premium user...